Insmed renegotiates Term Loan with Pharmakon Resulting in a Lower Cost of Capital and an Additional $150 Million in Proceeds to be Received in the Fourth Quarter

The content of this website is provided by Pharmakon Advisors, LP (“Pharmakon”) and offers information about Pharmakon and its affiliates and a general overview of its investment program. The content of this website is provided for information purposes only. Nothing on this website shall be construed as an offer to sell or a solicitation of an offer to purchase interests in any fund, private, publicly listed or otherwise, managed by Pharmakon, nor do they constitute investment advice. The information contained herein is subject to change without notice.

Please click on a transaction in order to view the corresponding press release.  Nothing in any applicable press release is intended to be, nor should be construed as, a testimonial or endorsement regarding Pharmakon as an investment adviser.  No compensation has been provided to any executives providing statements regarding Pharmakon, but, due to Pharmakon’s client’s investment in the relevant issuers, any statements made regarding Pharmakon in the press release involve an inherent conflict of interest.  To Pharmakon’s knowledge, none of the officers or directors of the borrowers quoted in any applicable press release are clients or investors in funds managed by Pharmakon.

Offers and sales will be made only in accordance with applicable securities laws and pursuant to a confidential private placement memorandum (or similar document) and other applicable fund governing documents, which should be read carefully and in their entirety prior to making an investment. Potential investors should not rely on any of the content of this website in making an investment or other decision but should obtain relevant and specific professional advice.

The content of this website and the investment program or the shares of any company which might be referred to therein are not directed at, or intended for, distribution, directly or indirectly, to any person or entity being a citizen or resident of, or located or established in, any jurisdiction where (i) the use of such websites or the sale of such investment programs would be illegal or would require any registration or licensing not held by Pharmakon, or (ii) to do so would constitute a violation of applicable law or regulation. Such persons or entities access this website at their own risk and must observe any legal or regulatory restrictions which may affect their eligibility to access this website.  Pharmakon makes no warranty or guarantee as to the accuracy, completeness or reliability of any information contained on this website. Pharmakon shall have no liability for any direct, indirect, consequential or special losses or damages of any kind whatsoever arising from reliance on any of the content of this website.

This website is for general information purposes only and is subject to change without notice. Nothing on this website is intended to and does not constitute financial, accounting, tax, legal, investment, consulting or other professional advice or services.